Publications by authors named "Ahmad Hashash"

Claim this Profile
D
Discovery of GS-9669, a thumb site II non-nucleoside inhibitor of NS5B for the treatment of genotype 1 chronic hepatitis C infection.
Scott E Lazerwith, Willard Lew, Jennifer Zhang, Philip Morganelli, Qi Liu, Ahmad Hashash

J Med Chem· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of GS-9669, a thumb site II inhibitor of the hepatitis C virus NS5B polymerase.
Martijn Fenaux, Stacey Eng, Stephanie A Leavitt, Yu-Jen Lee, Eric M Mabery, Ahmad Hashash

Antimicrob Agents Chemother· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors.
Savithri Ramurthy, Mina Aikawa, Payman Amiri, Abran Costales, Ahmad Hashash

Bioorg Med Chem Lett· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo.
Jennifer P Arbitrario, Brian J Belmont, Marc J Evanchik, W Michael Flanagan, Raymond V Fucini, Ahmad Hashash

Cancer Chemother Pharmacol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Water-soluble prodrugs of an Aurora kinase inhibitor.
Johan D Oslob, Stacey A Heumann, Chul H Yu, Darin A Allen, Subramanian Baskaran, Ahmad Hashash

Bioorg Med Chem Lett· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-HCV therapies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application.
Norman M Kneteman, Amy J Weiner, John O'Connell, Marc Collett, Tiejun Gao, Ahmad Hashash

Hepatology· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solubility, ionization, and partitioning behavior of unsymmetrical disulfide compounds: alkyl 2-imidazolyl disulfides.
Ahmad Hashash, D Lynn Kirkpatrick, John S Lazo, Lawrence H Block

J Pharm Sci· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal-phase and stability-indicating reversed-phase high-performance liquid chromatographic methods for the determination of the novel antitumor agent: 1-methylpropyl-2-imidazolyldisulfide.
Ahmad Hashash, D Lynn Kirkpatrick, Merrill J Egorin, Lawrence H Block, John S Lazo

J Chromatogr B Analyt Technol Biomed Life Sci· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis